Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 213 | 219 | 19 | 170 | 434 |
| Cost of Goods | 515 | 413 | 510 | 277 | 544 |
| Gross Profit | -302 | -194 | -491 | -107 | -110 |
| Operating Expenses | 945 | 783 | 835 | 742 | 1,015 |
| Operating Income | -732 | -563 | -816 | -572 | -581 |
| Interest Expense | 300 | 205 | 189 | 172 | 575 |
| Other Income | -31 | -11 | 0 | 79 | -73 |
| Pre-tax Income | -1,063 | -779 | -1,004 | -665 | -1,229 |
| Net Income Continuous | -1,063 | -779 | -1,004 | -665 | -1,229 |
| Net Income | $-1,063 | $-779 | $-1,004 | $-665 | $-1,229 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.05 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.05 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.05 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.05 |
| EBITDA(a) | $-575 | $-497 | $-762 | $-534 | $-559 |